Industry News
MoU to strengthen biomedical science partnership
The Australian Institute of Medical Scientists and the UK Institute of Biomedical Science have signed a memorandum of understanding that is intended to strengthen the partnership between the two organisations. [ + ]
FameLab's NSW semifinalists live on stage
Semifinalists in the science communication competition FameLab will take to the stage on 7 April at the Powerhouse Museum, Sydney. [ + ]
IDT's new manufacturing partner
WellSpring Pharma Services has agreed to manufacture two to three pharmaceutical products that require manufacturing processes or scale not currently available at IDT's Boronia facilities. [ + ]
Research Engagement and Impact working groups appointed
The Australian Research Council has announced the members of the two Engagement and Impact working groups that will assist in the development of a research engagement and impact assessment for Australia. [ + ]
Wet AMD trial completes patient enrolment
Opthea has completed patient enrolment in its ongoing phase 1 dose escalation clinical trial of OPT-302 as a novel therapy for wet age-related macular degeneration (wet AMD). [ + ]
Testing reproductive compatibility with fluorescent sperm
Scientists from The University of Western Australia have used fluorescent green dye to observe different sperm competing to fertilise eggs. [ + ]
Accelerating anticancer drug discovery
MecRx has secured a $4 million investment from the Medical Research Commercialisation Fund to advance its breakthrough technology for accelerating drug discovery. [ + ]
How to improve benchtop particle accelerators
Researchers have proposed a way to improve the beam quality of laser wakefield accelerators, also known as benchtop accelerators. [ + ]
Prostate Cancer Foundation opens 2016 funding round
The Prostate Cancer Foundation of Australia has opened its annual funding round with the aim of supporting groundbreaking prostate cancer research. [ + ]
An improved vaccine for World TB Day?
Two proteins from the tuberculosis bacterium are showing promising results in investigations in mice for a new vaccine. [ + ]
Phase IIb Parkinson's trial approved
Living Cell Technologies has received approval from the Auckland Hospital Research Review Committee for its Phase IIb clinical trial of NTCELL for Parkinson's disease. [ + ]
Standards set for the X-ray identification of bodies
Forensic researchers have established science-based standards for identifying human remains based on X-rays of an individual's spine, upper leg or the side of the skull. [ + ]
Expert Working Group to set Australia's research priorities
The Turnbull government has appointed the Expert Working Group that will help set the direction of Australia's research infrastructure and priorities over the coming decade. [ + ]
$20m in financing for blood-based bowel cancer test
OneVentures has closed a $19.7 million financing round for Clinical Genomics, an Australian company set to launch its next-generation blood-based diagnostic tool for colorectal cancer. [ + ]
Two trials to study wind farms and human health
The National Health and Medical Research Council has awarded grants totalling $3.3 million to two trials into the effects of wind farms on human health. [ + ]